These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 32117687)

  • 21. Debridement, Antibiotics, and Implant Retention in Periprosthetic Joint Infection: What Predicts Success or Failure?
    Toh RX; Yeo ZN; Liow MHL; Yeo SJ; Lo NN; Chen JY
    J Arthroplasty; 2021 Oct; 36(10):3562-3569. PubMed ID: 34116912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lower Success Rate of Débridement and Implant Retention in Late Acute versus Early Acute Periprosthetic Joint Infection Caused by Staphylococcus spp. Results from a Matched Cohort Study.
    Wouthuyzen-Bakker M; Sebillotte M; Huotari K; Escudero Sánchez R; Benavent E; Parvizi J; Fernandez-Sampedro M; Barbero JM; Garcia-Cañete J; Trebse R; Del Toro M; Diaz-Brito V; Sanchez M; Scarborough M; Soriano A;
    Clin Orthop Relat Res; 2020 Jun; 478(6):1348-1355. PubMed ID: 32106134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicting Failure in Early Acute Prosthetic Joint Infection Treated With Debridement, Antibiotics, and Implant Retention: External Validation of the KLIC Score.
    Löwik CAM; Jutte PC; Tornero E; Ploegmakers JJW; Knobben BAS; de Vries AJ; Zijlstra WP; Dijkstra B; Soriano A; Wouthuyzen-Bakker M;
    J Arthroplasty; 2018 Aug; 33(8):2582-2587. PubMed ID: 29691168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Staphylococcus lugdunensis prosthetic joint infection: A multicentric cohort study.
    Herry Y; Lesens O; Bourgeois G; Maillet M; Bricca R; Cazorla C; Karsenty J; Chroboczek T; Bouaziz A; Saison J; Langlois ME; Dupieux-Chabert C; Ferry T; Valour F;
    J Infect; 2022 Dec; 85(6):652-659. PubMed ID: 36273636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Debridement, Antibiotics, and Implant Retention for Acute Periprosthetic Joint Infection.
    Zhang CF; He L; Fang XY; Huang ZD; Bai GC; Li WB; Zhang WM
    Orthop Surg; 2020 Apr; 12(2):463-470. PubMed ID: 32159296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clindamycin-rifampin combination therapy for staphylococcal periprosthetic joint infections: a retrospective observational study.
    Leijtens B; Elbers JBW; Sturm PD; Kullberg BJ; Schreurs BW
    BMC Infect Dis; 2017 May; 17(1):321. PubMed ID: 28464821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prognosis of streptococcal prosthetic bone and joint infections depends on surgical management-A multicenter retrospective study.
    Mahieu R; Dubée V; Seegers V; Lemarié C; Ansart S; Bernard L; Le Moal G; Asseray N; Arvieux C; Ramanantsoa C; Cormier H; Legrand E; Abgueguen P;
    Int J Infect Dis; 2019 Aug; 85():175-181. PubMed ID: 31212103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of treatment outcome in prosthetic joint infections treated with prosthesis retention.
    Puhto AP; Puhto T; Niinimäki T; Ohtonen P; Leppilahti J; Syrjälä H
    Int Orthop; 2015 Sep; 39(9):1785-91. PubMed ID: 26138772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional outcome of debridement, antibiotics and implant retention in periprosthetic joint infection involving the hip: a case-control study.
    Grammatopoulos G; Bolduc ME; Atkins BL; Kendrick BJL; McLardy-Smith P; Murray DW; Gundle R; Taylor AH
    Bone Joint J; 2017 May; 99-B(5):614-622. PubMed ID: 28455470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comment on "Duration of rifampin therapy is a key determinant of improved outcomes in early-onset acute prosthetic joint infection due to Staphylococcus treated with a debridement, antibiotics and implant retention (DAIR): a retrospective multicenter study in France" by Becker et al. (2020).
    Scheper H; de Boer MGJ
    J Bone Jt Infect; 2020; 6(1):17-18. PubMed ID: 32983843
    [No Abstract]   [Full Text] [Related]  

  • 31. Debridement, antibiotics and implant retention in early periprosthetic joint infection.
    Bergkvist M; Mukka SS; Johansson L; Ahl TE; Sayed-Noor AS; Sköldenberg OG; Eisler T
    Hip Int; 2016; 26(2):138-43. PubMed ID: 26868114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Failed Debridement and Implant Retention Does Not Compromise the Success of Subsequent Staged Revision in Infected Total Knee Arthroplasty.
    Kim K; Zhu M; Cavadino A; Munro JT; Young SW
    J Arthroplasty; 2019 Jun; 34(6):1214-1220.e1. PubMed ID: 30826164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Double DAIR: A 2-Stage Debridement with Prosthesis-Retention Protocol for Acute Periprosthetic Joint Infections.
    McQuivey KS; Bingham J; Chung A; Clarke H; Schwartz A; Pollock JR; Beauchamp C; Spangehl MJ
    JBJS Essent Surg Tech; 2021; 11(1):. PubMed ID: 34123550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Debridement, antimicrobials, and implant retention in the treatment of late acute and early acute
    Huotari K; Vuorinen M; Vasara A
    Infect Dis (Lond); 2023 Aug; 55(8):525-532. PubMed ID: 37255321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome of Debridement, Antibiotics, and Implant Retention for Staphylococcal Hip and Knee Prosthetic Joint Infections, Focused on Rifampicin Use: A Systematic Review and Meta-Analysis.
    Scheper H; Gerritsen LM; Pijls BG; Van Asten SA; Visser LG; De Boer MGJ
    Open Forum Infect Dis; 2021 Jul; 8(7):ofab298. PubMed ID: 34258321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk Factors of DAIR Failure and Validation of the KLIC Score: A Multicenter Study of Four Hundred Fifty-Five Patients.
    Bernaus M; Auñón-Rubio Á; Monfort-Mira M; Arteagoitia-Colino I; Martínez-Ros J; Castellanos J; Lamo-Espinosa JM; Argüelles F; Veloso M; Gómez García L; Crespo FA; Sánchez-Fernández J; Murias-Álvarez J; Martí-Garín D; Hernández-González N; Villarejo-Fernández B; Valero-Cifuentes G; Hernández-Torres A; Molina-González J; Coifman-Lucena I; Esteban-Moreno J; Demaria P; Esteve-Palau E; Del Pozo JL; Suárez Á; Carmona-Torre F; Darás Á; Baeza J; Font-Vizcarra L
    Surg Infect (Larchmt); 2022 Apr; 23(3):280-287. PubMed ID: 35172116
    [No Abstract]   [Full Text] [Related]  

  • 37. Reply to Scheper and de Boer's comment on "Duration of rifampin therapy is a key determinant of improved outcomes in early-onset acute prosthetic joint infection due to Staphylococcus treated with a debridement, antibiotics and implant retention (DAIR): a retrospective multicenter study in France" by Becker et al. (2020).
    Becker A; Kreitmann L; Ferry T
    J Bone Jt Infect; 2020; 6(1):19-20. PubMed ID: 32983844
    [No Abstract]   [Full Text] [Related]  

  • 38. For Patients With Acute PJI Treated With Debridement, Antibiotics, and Implant Retention, What Factors Are Associated With Systemic Sepsis and Recurrent or Persistent Infection in Septic Patients?
    Ludwick L; Siqueira M; Shohat N; Sherman MB; Streicher S; Parvizi J
    Clin Orthop Relat Res; 2022 Aug; 480(8):1491-1500. PubMed ID: 35420556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome of debridement and retention in prosthetic joint infections by methicillin-resistant staphylococci, with special reference to rifampin and fusidic acid combination therapy.
    Peel TN; Buising KL; Dowsey MM; Aboltins CA; Daffy JR; Stanley PA; Choong PF
    Antimicrob Agents Chemother; 2013 Jan; 57(1):350-5. PubMed ID: 23114758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is DAIR Still an Effective Way to Eradicate Acute Prosthetic Joint Infections? Our Experience in the Jordanian Royal Medical Services.
    Ghnaimat M; Alyamani A; Obeidat M; Jbarat A; Abushahot M
    Med Arch; 2021 Dec; 75(6):451-455. PubMed ID: 35169373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.